Status:
COMPLETED
BOTOX® Prophylaxis in Patients With Chronic Migraine
Lead Sponsor:
Allergan
Conditions:
Migraine Disorders
Eligibility:
All Genders
18+ years
Brief Summary
This is a post authorization observational study to monitor the utilization practices and describe the safety profile of BOTOX® in clinical practice for the prophylactic treatment of headaches in adul...
Eligibility Criteria
Inclusion
- Diagnosis of chronic migraine
- Willing to use BOTOX® as preventative treatment for migraine
Exclusion
- None
Key Trial Info
Start Date :
September 9 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 12 2015
Estimated Enrollment :
1168 Patients enrolled
Trial Details
Trial ID
NCT01432379
Start Date
September 9 2011
End Date
May 12 2015
Last Update
January 8 2019
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Munich, Germany
2
Oviedo, Spain
3
Stockholm, Sweden
4
London, United Kingdom